Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Inna D'Empaire, MD

Articles by Inna D'Empaire, MD

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
February 3rd 2025

Trending on Psychiatric Times

When Antidepressants Stop Working: Understanding Tachyphylaxis in Clinical Practice

Sleep Disruption and Alzheimer Disease: A Bidirectional, Treatable Relationship

What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?

New Multi-Arm, Multi-Stage UK Trial to Test Alzheimer Treatments

FDA Aligns on Key Elements of Phase 3 Study of Zervimesine for Dementia With Lewy Bodies